Researchers are exploring the use of digital microfluidics for next-generation point-of-care diagnostics, including nucleic acid amplification tests. Various technologies and systems are being developed, such as lab-on-pcb and microfluidic devices, to enable automated and integrated detection of pathogens and other targets. These advancements aim to improve point-of-care diagnostics, but the specific applications and outcomes of these developments are still being researched and reported.